The JI
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
QUICK SEARCH:   [advanced]


     
 

This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Related articles in The JI
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow Request Permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Roopenian, D. C.
Right arrow Articles by Anderson, C. L.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Roopenian, D. C.
Right arrow Articles by Anderson, C. L.
The Journal of Immunology, 2003, 170: 3528-3533.
Copyright © 2003 by The American Association of Immunologists

The MHC Class I-Like IgG Receptor Controls Perinatal IgG Transport, IgG Homeostasis, and Fate of IgG-Fc-Coupled Drugs1

Derry C. Roopenian2,*, Gregory J. Christianson*, Thomas J. Sproule*, Aaron C. Brown*, Shreeram Akilesh*, Nadja Jung*, Stefka Petkova*, Lia Avanessian*, Eun Young Choi*, Daniel J. Shaffer*, Peter A. Eden* and Clark L. Anderson{dagger}

* The Jackson Laboratory, Bar Harbor, ME 04609; and {dagger} Ohio State University, Columbus, OH 43210

Abs of the IgG isotype are efficiently transported from mother to neonate and have an extended serum t1/2 compared with Abs of other isotypes. Circumstantial evidence suggests that the MHC class I-related protein, the neonatal FcR (FcRn), is the FcR responsible for both in vivo functions. To understand the phenotypes imposed by FcRn, we produced and analyzed mice with a defective FcRn gene. The results provide direct evidence that perinatal IgG transport and protection of IgG from catabolism are mediated by FcRn, and that the latter function is key to IgG homeostasis, essential for generating a potent IgG response to foreign Ags, and the basis of enhanced efficacy of Fc-IgG-based therapeutics. FcRn is therefore a promising therapeutic target for enhancing protective humoral immunity, treating autoimmune disease, and improving drug efficacy.


Related articles in The JI:

IN THIS ISSUE

The JI 2003 170: 3449-3450. [Full Text]  



This article has been cited by other articles:


Home page
 J. Am. Soc. Nephrol.Home page
M. Sarav, Y. Wang, B. K. Hack, A. Chang, M. Jensen, L. Bao, and R. J. Quigg
Renal FcRn Reclaims Albumin but Facilitates Elimination of IgG
J. Am. Soc. Nephrol., September 1, 2009; 20(9): 1941 - 1952.
[Abstract] [Full Text] [PDF]

Home page
 J. Immunol.Home page
Y. A. Yeung, M. K. Leabman, J. S. Marvin, J. Qiu, C. W. Adams, S. Lien, M. A. Starovasnik, and H. B. Lowman
Engineering Human IgG1 Affinity to Human Neonatal Fc Receptor: Impact of Affinity Improvement on Pharmacokinetics in Primates
J. Immunol., June 15, 2009; 182(12): 7663 - 7671.
[Abstract] [Full Text] [PDF]

Home page
 Mol. Pharmacol.Home page
S.-C. Lu, J. Xu, N. Chinookoswong, S. Liu, S. Steavenson, C. Gegg, D. Brankow, R. Lindberg, M. Veniant, and W. Gu
An Acyl-Ghrelin-Specific Neutralizing Antibody Inhibits the Acute Ghrelin-Mediated Orexigenic Effects in Mice
Mol. Pharmacol., April 1, 2009; 75(4): 901 - 907.
[Abstract] [Full Text] [PDF]

Home page
 J. Immunol.Home page
J. Kim, S. Mohanty, L. P. Ganesan, K. Hua, D. Jarjoura, W. L. Hayton, J. M. Robinson, and C. L. Anderson
FcRn in the Yolk Sac Endoderm of Mouse Is Required for IgG Transport to Fetus
J. Immunol., March 1, 2009; 182(5): 2583 - 2589.
[Abstract] [Full Text] [PDF]

Home page
 Proc. Natl. Acad. Sci. USAHome page
H. P. Montoyo, C. Vaccaro, M. Hafner, R. J. Ober, W. Mueller, and E. S. Ward
Conditional deletion of the MHC class I-related receptor FcRn reveals the sites of IgG homeostasis in mice
PNAS, February 24, 2009; 106(8): 2788 - 2793.
[Abstract] [Full Text] [PDF]

Home page
 Proc. Natl. Acad. Sci. USAHome page
J. A. Bubier, T. J. Sproule, O. Foreman, R. Spolski, D. J. Shaffer, H. C. Morse III, W. J. Leonard, and D. C. Roopenian
A critical role for IL-21 receptor signaling in the pathogenesis of systemic lupus erythematosus in BXSB-Yaa mice
PNAS, February 3, 2009; 106(5): 1518 - 1523.
[Abstract] [Full Text] [PDF]

Home page
 Molecular Cancer TherapeuticsHome page
C. F. McDonagh, K. M. Kim, E. Turcott, L. L. Brown, L. Westendorf, T. Feist, D. Sussman, I. Stone, M. Anderson, J. Miyamoto, et al.
Engineered anti-CD70 antibody-drug conjugate with increased therapeutic index
Mol. Cancer Ther., September 1, 2008; 7(9): 2913 - 2923.
[Abstract] [Full Text] [PDF]

Home page
 Proc. Natl. Acad. Sci. USAHome page
T. Hofer, J. D. Thomas, T. R. Burke Jr., and C. Rader
An engineered selenocysteine defines a unique class of antibody derivatives
PNAS, August 26, 2008; 105(34): 12451 - 12456.
[Abstract] [Full Text] [PDF]

Home page
 J. Immunol.Home page
L. Ye, X. Liu, S. N. Rout, Z. Li, Y. Yan, L. Lu, T. Kamala, N. K. Nanda, W. Song, S. K. Samal, et al.
The MHC Class II-Associated Invariant Chain Interacts with the Neonatal Fc{gamma} Receptor and Modulates Its Trafficking to Endosomal/Lysosomal Compartments
J. Immunol., August 15, 2008; 181(4): 2572 - 2585.
[Abstract] [Full Text] [PDF]

Home page
 J. Immunol.Home page
X. Liu, L. Ye, Y. Bai, H. Mojidi, N. E. Simister, and X. Zhu
Activation of the JAK/STAT-1 Signaling Pathway by IFN-{gamma} Can Down-Regulate Functional Expression of the MHC Class I-Related Neonatal Fc Receptor for IgG
J. Immunol., July 1, 2008; 181(1): 449 - 463.
[Abstract] [Full Text] [PDF]

Home page
 Proc. Natl. Acad. Sci. USAHome page
J. H. Grubb, C. Vogler, Y. Tan, G. N. Shah, A. F. MacRae, and W. S. Sly
Infused Fc-tagged {beta}-glucuronidase crosses the placenta and produces clearance of storage in utero in mucopolysaccharidosis VII mice
PNAS, June 17, 2008; 105(24): 8375 - 8380.
[Abstract] [Full Text] [PDF]

Home page
 Exp. Biol. Med.Home page
J. Kim, C. L. Bronson, M. A. Wani, T. M. Oberyszyn, S. Mohanty, C. Chaudhury, W. L. Hayton, J. M. Robinson, and C. L. Anderson
{beta}2-Microglobulin Deficient Mice Catabolize IgG More Rapidly Than FcRn-{alpha}-Chain Deficient Mice
Experimental Biology and Medicine, May 1, 2008; 233(5): 603 - 609.
[Abstract] [Full Text] [PDF]

Home page
 Proc. Natl. Acad. Sci. USAHome page
A. R. Mezo, K. A. McDonnell, C. A. T. Hehir, S. C. Low, V. J. Palombella, J. M. Stattel, G. D. Kamphaus, C. Fraley, Y. Zhang, J. A. Dumont, et al.
Reduction of IgG in nonhuman primates by a peptide antagonist of the neonatal Fc receptor FcRn
PNAS, February 19, 2008; 105(7): 2337 - 2342.
[Abstract] [Full Text] [PDF]

Home page
 Proc. Natl. Acad. Sci. USAHome page
S. Akilesh, T. B. Huber, H. Wu, G. Wang, B. Hartleben, J. B. Kopp, J. H. Miner, D. C. Roopenian, E. R. Unanue, and A. S. Shaw
From the Cover: Podocytes use FcRn to clear IgG from the glomerular basement membrane
PNAS, January 22, 2008; 105(3): 967 - 972.
[Abstract] [Full Text] [PDF]

Home page
 J. Immunol.Home page
S. Akilesh, G. J. Christianson, D. C. Roopenian, and A. S. Shaw
Neonatal FcR Expression in Bone Marrow-Derived Cells Functions to Protect Serum IgG from Catabolism
J. Immunol., October 1, 2007; 179(7): 4580 - 4588.
[Abstract] [Full Text] [PDF]

Home page
 J. Immunol.Home page
X. Liu, L. Ye, G. J. Christianson, J.-Q. Yang, D. C. Roopenian, and X. Zhu
NF-{kappa}B Signaling Regulates Functional Expression of the MHC Class I-Related Neonatal Fc Receptor for IgG via Intronic Binding Sequences
J. Immunol., September 1, 2007; 179(5): 2999 - 3011.
[Abstract] [Full Text] [PDF]

Home page
 Biol. Reprod.Home page
J. C. Cooper, G. B. Dealtry, M. A. Ahmed, P. C. Arck, B. F. Klapp, S. M. Blois, and N. Fernandez
An Impaired Breeding Phenotype in Mice with a Genetic Deletion of Beta-2 Microglobulin and Diminished MHC Class I Expression: Role in Reproductive Fitness
Biol Reprod, August 1, 2007; 77(2): 274 - 279.
[Abstract] [Full Text] [PDF]

Home page
 J. Immunol.Home page
L. Liu, A. M. Garcia, H. Santoro, Y. Zhang, K. McDonnell, J. Dumont, and A. Bitonti
Amelioration of Experimental Autoimmune Myasthenia Gravis in Rats by Neonatal FcR Blockade
J. Immunol., April 15, 2007; 178(8): 5390 - 5398.
[Abstract] [Full Text] [PDF]

Home page
 JEMHome page
F. Nimmerjahn and J. V. Ravetch
The antiinflammatory activity of IgG: the intravenous IgG paradox
J. Exp. Med., January 22, 2007; 204(1): 11 - 15.
[Abstract] [Full Text] [PDF]

Home page
 Proc. Natl. Acad. Sci. USAHome page
C. Vaccaro, R. Bawdon, S. Wanjie, R. J. Ober, and E. S. Ward
Divergent activities of an engineered antibody in murine and human systems have implications for therapeutic antibodies
PNAS, December 5, 2006; 103(49): 18709 - 18714.
[Abstract] [Full Text] [PDF]

Home page
 Int ImmunolHome page
S. B. Petkova, S. Akilesh, T. J. Sproule, G. J. Christianson, H. Al Khabbaz, A. C. Brown, L. G. Presta, Y. G. Meng, and D. C. Roopenian
Enhanced half-life of genetically engineered human IgG1 antibodies in a humanized FcRn mouse model: potential application in humorally mediated autoimmune disease
Int. Immunol., December 1, 2006; 18(12): 1759 - 1769.
[Abstract] [Full Text] [PDF]

Home page
 J. Nutr.Home page
C. Chaudhury, J. Kim, S. Mehnaz, M. A. Wani, T. M. Oberyszyn, C. L. Bronson, S. Mohanty, W. L. Hayton, J. M. Robinson, and C. L. Anderson
Accelerated Transferrin Degradation in HFE-Deficient Mice Is Associated with Increased Transferrin Saturation
J. Nutr., December 1, 2006; 136(12): 2993 - 2998.
[Abstract] [Full Text] [PDF]

Home page
 BloodHome page
G. Vidarsson, A. M. Stemerding, N. M. Stapleton, S. E. Spliethoff, H. Janssen, F. E. Rebers, M. de Haas, and J. G. van de Winkel
FcRn: an IgG receptor on phagocytes with a novel role in phagocytosis
Blood, November 15, 2006; 108(10): 3573 - 3579.
[Abstract] [Full Text] [PDF]

Home page
 Am. J. Pathol.Home page
E. Maidji, S. McDonagh, O. Genbacev, T. Tabata, and L. Pereira
Maternal Antibodies Enhance or Prevent Cytomegalovirus Infection in the Placenta by Neonatal Fc Receptor-Mediated Transcytosis
Am. J. Pathol., April 1, 2006; 168(4): 1210 - 1226.
[Abstract] [Full Text] [PDF]

Home page
 Int ImmunolHome page
H. Crowley, J. Alroy, T. J. Sproule, D. Roopenian, and B. T. Huber
The MHC class I-related FcRn ameliorates murine Lyme arthritis
Int. Immunol., March 1, 2006; 18(3): 409 - 414.
[Abstract] [Full Text] [PDF]

Home page
 J. Virol.Home page
K. M. Chung, G. E. Nybakken, B. S. Thompson, M. J. Engle, A. Marri, D. H. Fremont, and M. S. Diamond
Antibodies against West Nile Virus Nonstructural Protein NS1 Prevent Lethal Infection through Fc {gamma} Receptor-Dependent and -Independent Mechanisms
J. Virol., February 1, 2006; 80(3): 1340 - 1351.
[Abstract] [Full Text] [PDF]

Home page
 Am. J. Physiol. Gastrointest. Liver Physiol.Home page
J. Kim, C. L. Bronson, W. L. Hayton, M. D. Radmacher, D. C. Roopenian, J. M. Robinson, and C. L. Anderson
Albumin turnover: FcRn-mediated recycling saves as much albumin from degradation as the liver produces
Am J Physiol Gastrointest Liver Physiol, February 1, 2006; 290(2): G352 - G360.
[Abstract] [Full Text] [PDF]

Home page
 Infect. Immun.Home page
L. Bry, M. Brigl, and M. B. Brenner
CD4+-T-Cell Effector Functions and Costimulatory Requirements Essential for Surviving Mucosal Infection with Citrobacter rodentium
Infect. Immun., January 1, 2006; 74(1): 673 - 681.
[Abstract] [Full Text] [PDF]

Home page
 J. Immunol.Home page
P. R. Hinton, J. M. Xiong, M. G. Johlfs, M. T. Tang, S. Keller, and N. Tsurushita
An Engineered Human IgG1 Antibody with Longer Serum Half-Life
J. Immunol., January 1, 2006; 176(1): 346 - 356.
[Abstract] [Full Text] [PDF]

Home page
 Proc. Natl. Acad. Sci. USAHome page
N. Savelyeva, C. A. King, E. S. Vitetta, and F. K. Stevenson
Inhibition of a vaccine-induced anti-tumor B cell response by soluble protein antigen in the absence of continuing T cell help
PNAS, August 2, 2005; 102(31): 10987 - 10992.
[Abstract] [Full Text] [PDF]

Home page
 J. Immunol.Home page
X. Zhu, J. Peng, D. Chen, X. Liu, L. Ye, H. Iijima, K. Kadavil, W. I. Lencer, and R. S. Blumberg
Calnexin and ERp57 Facilitate the Assembly of the Neonatal Fc Receptor for IgG with {beta}2-Microglobulin in the Endoplasmic Reticulum
J. Immunol., July 15, 2005; 175(2): 967 - 976.
[Abstract] [Full Text] [PDF]

Home page
 J. Cell Sci.Home page
E. E. Newton, Z. Wu, and N. E. Simister
Characterization of basolateral-targeting signals in the neonatal Fc receptor
J. Cell Sci., June 1, 2005; 118(11): 2461 - 2469.
[Abstract] [Full Text] [PDF]

Home page
 aacredbookHome page
P. Carter and C. F. McDonagh
Designer Antibody-Based Therapeutics for Oncology
Am. Assoc. Cancer Res. Educ. Book, April 1, 2005; 2005(1): 147 - 154.
[Full Text] [PDF]

Home page
 J. Biol. Chem.Home page
N. L. B. Wernick, V. Haucke, and N. E. Simister
Recognition of the Tryptophan-based Endocytosis Signal in the Neonatal Fc Receptor by the {micro} Subunit of Adaptor Protein-2
J. Biol. Chem., February 25, 2005; 280(8): 7309 - 7316.
[Abstract] [Full Text] [PDF]

Home page
 Cancer Res.Home page
V. Kenanova, T. Olafsen, D. M. Crow, G. Sundaresan, M. Subbarayan, N. H. Carter, D. N. Ikle, P. J. Yazaki, A. F. Chatziioannou, S. S. Gambhir, et al.
Tailoring the Pharmacokinetics and Positron Emission Tomography Imaging Properties of Anti-Carcinoembryonic Antigen Single-Chain Fv-Fc Antibody Fragments
Cancer Res., January 15, 2005; 65(2): 622 - 631.
[Abstract] [Full Text] [PDF]


HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
This Website Copyright © 2003 by The American Association of Immunologists, Inc. All rights reserved.
All Contents Copyright © 2003 by The American Association of Immunologists, Inc. All rights reserved.